Skip to main content

Table 4 Associations* between components of metabolic syndrome and carotid atherosclerosis after 13 years

From: The metabolic syndrome and progression of carotid atherosclerosis over 13 years. The Tromsø study

 

Follow-up levels

Change from baseline to follow-up

 

IMT (mm)

TPA(mm²)

ΔIMT (mm)

ΔTPA(mm²)

 

β

p

β

p

β

p

β

p

Men

        

Age

0.008

<0.0001

0.102

<0.0001

-

-

0.031

<0.0001

Components of MetS

        

Hypertension

0.045

0.0004

0.642

0.0003

-

-

-

-

Abdominal obesity

-

-

-

-

-

-

-

-

Hypertriglyceridemia

0.029

0.01

-

-

-

-

-

-

Low HDL-level

-

-

-

-

-

-

-

-

Impaired glucose tolerance

0.102

0.001

1.129

0.01

0.075

0.006

-

-

LDL cholesterol

0.013

0.02

0.263

0.0006

-

-

-

-

Daily smoking

0.04

0.0001

1.134

<0.0001

0.021

0.006

0.516

0.001

Women

        

Age

0.008

<0.0001

0.073

<0.0001

0.002

<0.0001

0.027

<0.0001

Components of MetS

        

Hypertension

0.041

<0.0001

0.643

<0.0001

-

-

0.308

0.02

Abdominal obesity

-

-

-

-

-

-

-

-

Hypertriglyceridemia

0.026

0.014

-

-

-

-

-

-

Low HDL-level

0.031

0.012

-

-

-

-

-

-

Impaired glucose tolerance

-

-

-

-

-

-

-

-

LDL cholesterol

0.021

<0.0001

0.425

<0.0001

-

-

0.195

0.0004

Daily smoking

0.025

0.025

0.956

<0.0001

0.034

0.0008

0.537

<0.0001

  1. * Stepwise multivariable linear regression analysis with forward selection and significance level 0.05 for entry into the model.
  2. †square-root-transformed values were used in the analyses.
  3. ‡p values for β-coefficient.
  4. MetS; metabolic syndrome, HDL; high-density lipoprotein cholesterol, LDL; low-density lipoprotein cholesterol.
  5. The Tromsø Study.